Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human PERP Antibody (SAA1879)

Catalog #:   RHN04401 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA
Accession: Q96FX8
Overview

Catalog No.

RHN04401

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

p53 apoptosis effector related to PMP-22, PERP, THW, Transmembrane protein THW, P53-induced protein PIGPC1, KCP1, PIGPC1, KCP-1, Keratinocyte-associated protein 1, KRTCAP1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q96FX8

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1879

Data Image
References

Isolation, purification, structure elucidation, and antibody recognition of two phospholipases A2 and Crotoxin variation in the venom of the Tamaulipan rattlesnake Crotalus morulus., PMID:40499607

Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B., PMID:40499172

Trem2 regulates microglial migratory responses via type I interferon signaling during photoreceptor degeneration., PMID:40468324

Artificial intelligence-based Raynaud's quantification index (ARTIX): an objective mobile-based tool for patient-centered assessment of Raynaud's phenomenon., PMID:40462205

Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study., PMID:40442445

NKG2D triggering hampers DNAM-1-mediated signaling in human NK cells., PMID:40421025

Anti-MDA5 antibody positive dermatomyositis complicated by interstitial lung disease with an improved outcome: A case report., PMID:40419927

Spontaneous Intramuscular Hemorrhage in Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis., PMID:40416002

[Update Raynaud Phenomenon]., PMID:40388975

Hand swelling and other non-Raynaud's symptoms as the initial presentation of systemic sclerosis: prevalence and clinical associations in two U.S. cohorts., PMID:40386907

A Diagnostic Uncertainty in an Immunocompromised Patient: Rapidly Progressive Interstitial Lung Disease vs. Pneumocystis Pneumonia., PMID:40376365

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta., PMID:40372913

The Role of Anti-MDA5 Antibodies in Rapidly Progressive Interstitial Lung Disease: A Case Report and Literature Review., PMID:40370246

GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial., PMID:40360471

Lyme Disease., PMID:40354663

A novel DNA sequence-selective, guanine mono-alkylating ADC payload suitable for solid tumour treatment., PMID:40352674

The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis., PMID:40333247

Human intravenous immunoglobulins for recurrent pericarditis: a multicentre cohort study., PMID:40293818

Experimental Efficacy of an Alphavirus Vectored RNA Particle Vaccine Against Porcine Parainfluenza Virus-1 in Conventional Weaned Pigs., PMID:40285006

Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study., PMID:40276503

Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies., PMID:40260187

Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial., PMID:40255182

Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis., PMID:40241163

Alcohol-based solvents as mobile phases for LC-MS characterization of therapeutic proteins., PMID:40220636

The association between chronic underlying diseases and the clinical characteristics in adult patients infected with Omicron BA.1., PMID:40213468

Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab., PMID:40186086

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study., PMID:40175336

Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis., PMID:40168091

Perceptions of patients with inflammatory bowel diseases on switching from reference product adalimumab to biosimilar adalimumab-atto., PMID:40167456

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism., PMID:40164778

Discovery and Characterization of Novel G0 Glycan Isomers in an Afucosylated Therapeutic Antibody Using Liquid Chromatography-Mass Spectrometry., PMID:40163010

Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center., PMID:40156631

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial., PMID:40154210

Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates., PMID:40143253

Common Haplotypes within the Chromosome 1q31.3 Region Determine Systemic Concentrations of the Entire Complement Factor H Protein Family., PMID:40139172

Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis., PMID:40124434

SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)., PMID:40118946

Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study., PMID:40114144

Amyopathic dermatomyositis associated with immune checkpoint inhibitor therapy in lung adenocarcinoma: a case report., PMID:40104725

From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates., PMID:40098704

Human scalp hair follicles can 'taste': chemosensory signalling via the bitter taste receptor TAS2R4 inhibits hair growth ex vivo., PMID:40097020

Splenic red pulp macrophages eliminate the liver-resistant Streptococcus pneumoniae from the blood circulation of mice., PMID:40073120

Retinal Vascularization Rate Predicts Retinopathy of Prematurity and Remains Unaffected by Low-Dose Bevacizumab Treatment., PMID:40054545

Development and characterization of Dot Blot detection assay for the diagnosis of acanthamoeba keratitis., PMID:40048970

Targeting FAK improves the tumor uptake of antibody-drug conjugates to strengthen the anti-cancer responses., PMID:40040813

A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction., PMID:40037346

Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing Multiple Sclerosis., PMID:40036713

Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial., PMID:40015292

Efficacy of etanercept biosimilar switching from etanercept reference product, using ultrasound and clinical data in outcomes of real world therapy (ESCORT-NGSK Study)., PMID:40010737

TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders., PMID:40010414

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human PERP Antibody (SAA1879) [RHN04401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only